Keywords: neurosearch, brasofensine, collaboration, b-ms, terminated, widely, expected

NeuroSearch brasofensine collaboration with B-MS terminated

Article | 29 June 1999

Print This

As widely expected, Bristol-Myers Squibb and NeuroSearch have endedtheir agreement for the latter's anti-Parkinson's drug brasofensine.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in